Stock listing

Co-diagnostics, Inc.

Selected listing: 0A50 · LSE · USD · GB

Co-diagnostics, Inc. (LSE:0A50), Health Technology. Latest release Oct 6, 2026: Co-Diagnostics to Showcase Co-Dx PCR Platform and MTB Test at WHX Labs…

0A50:LSEUSDGBUpdated October 2, 2026

Ticker: LSE:0A50
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: LSE
Currency: USD

Latest news from Co-diagnostics, Inc.

Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development

October 6, 2026

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week

September 23, 2026

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation

September 21, 2026

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026

September 17, 2026

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

September 16, 2026

All Co-diagnostics, Inc. news →

Events

Replays

Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 04:30 PM ET
Watch
Co-Diagnostics, Inc. (CODX) Q1 2026 Earnings Call
Thu, May 14, 2026 · 04:30 PM ET
Watch
Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call
Tue, Mar 31, 2026 · 04:30 PM ET
Watch

Research Co-diagnostics, Inc.

Co-diagnostics, Inc. company profile

View the public company page for Co-diagnostics, Inc. on 6ix.

Co-diagnostics, Inc. news

Read company news and market updates connected to Co-diagnostics, Inc..

Co-diagnostics, Inc. investor events

Find investor webinars, events, and replay context for Co-diagnostics, Inc..